covid
Buscar en
Allergologia et Immunopathologia
Toda la web
Inicio Allergologia et Immunopathologia The effects of daily pulmonary rehabilitation program at home on childhood asthm...
Información de la revista
Vol. 28. Núm. 1.
Páginas 12-14 (febrero 2000)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 28. Núm. 1.
Páginas 12-14 (febrero 2000)
Acceso a texto completo
The effects of daily pulmonary rehabilitation program at home on childhood asthma
The effects of daily pulmonary rehabilitation program at home on childhood asthma
Visitas
4978
G. Bingöl Karakoç, M. Yilmaz, S. Sur, D. Ufuk Altintas, T Sarpel and S Güneter Kendirli
Este artículo ha recibido
Información del artículo
Texto completo

The effects of daily pulmonary rehabilitation program at home on childhood asthma

G. Bingöl Karakoç*, M. Yilmaz*, S. Sur**, D. Ufuk Altintas, *, T. Sarpel**and S. Güneter Kendirli*

*Çukurova University. Faculty of Medicine. Division of Pediatric Allergy-Immunology. 

**Department of Physical Medicine and Rehabilitation. Adana. Turkey.

Correspondence:

Dr. Gülbin Bingöl Karakoç

Department of Pediatric Allergy and Immunology, Çukurova University Faculty of Medicine

01330 Adana

Turkey

E-mail: gulbin2@yahoo.com


SUMMARY

Objective: the aim of this study is to investigate the efficacy of pulmonary rehabilitation program in children with asthma.

Patients and method: twenty eight children with mild persistent or moderate asthma were included into a double blind, randomised study. Sixteen children (9 girls , 7 boys) with the mean age of 10.8 ± 2.3 were assigned to receive pulmonary rehabilitation program with their parents for 30 days (group I). Control group included 12 children (6 girls, 6 boys ) with the mean age of 10.2 ± 2.4 (group II). Symptom and medication scores quality of life index and pulmonary function tests were evaluated in rehabilitation and control group in the beginning of the study and after the one month period.

Results: the groups did not differ on all parameters before the study (p > 0.05). Statistically significant decrease were found in symptom and medication scores in rehabilitation group (p < 0.05) and quality of life index was increased significantly in the same group (p < 0.05). Pulmonary function measures also significantly improved including vital capacity, forced vital capacity, FEV1, PEF and FEF25-75 in the rehabilitation group (p < 0.05). The best improvement were seen in FEF25-75 (10.09% increase) and PEF (7.81% increase) values. In control group no statistically significant differences were found in all parameters.

Conclusion: in this study it was shown that daily pulmonary rehabilitation at home could improve quality of life and pulmonary functions. So pulmonary rehabilitation should be placed as a component of management in childhood asthma.

Key words: Pulmonary rehabilitation. Childhood, asthma.

RESUMEN

Objetivos: el objetivo de este estudio fue investigar la eficacia de un programa de rehabilitación pulmonar para niños asmáticos.

Pacientes y método: veintiocho niños con asma leve persistente o moderada fueron incluidos en un estudio aleatorio doble ciego. Dieciséis niños (9 chicas y 7 chicos, edad media 10,8 ± 2,3 años) fueron incluidos en un programa de rehabilitación pulmonar de 30 días de duración que realizaron con sus padres (grupo I). El grupo control incluyó 12 niños (6 chicas y 6 chicos, edad media 10,2 ± 2,4 años) (grupo II). Se evaluaron las puntuaciones por síntomas y el consumo de fármacos, el índice de la calidad de vida y las pruebas de función pulmonar en los grupos de rehabilitación y control al principio del estudio y después de un intervalo de un mes.

Resultados: antes del estudio no se encontró ninguna diferencia entre grupos en los parámetros (p > 0,05). Después de un mes de rehabilitación, se encontró una disminución estadísticamente significativa en las puntuaciones por síntomas y consumo de fármacos (p < 0,05) y un índice de calidad de vida significativamente mayor (p < 0,05). Las mediciones de función pulmonar también mejoraron significativamente, incluyendo la capacidad vital, capacidad vital forzada, FEV1, PEF y FEF25-75 en el grupo de rehabilitación (p < 0,05). La máxima mejoría se constató en los valores del FEF25-75 (un incremento del 10,09%) y PEF (un incremento del 7,81%). No se observó ningún cambio estadísticamente significativo en los parámetros del grupo control.

Conclusión: este estudio ha demostrado que un programa de rehabilitación pulmonar diaria en el domicilio puede mejorar la calidad de vida y función pulmonar. Por lo tanto, la rehabilitación pulmonar debería incluirse en el tratamiento del asma infantil.

Palabras clave: Rehabilitación pulmonar. Infancia. Asma.


INTRODUCTION

A number of patients with chronic obstructive pulmonary diseases and asthma is on the rise over all the world. Education, environmental control and drug therapy are the corner stones in the management of asthma. Nowadays pulmonary rehabilitation is a recognised discipline for stabilisation and improvement of asthma and chronic obstructive pulmonary diseases. Pulmonary rehabilitation program (PRP) could improve the quality of life, pulmonary functions, exercise tolerance, reduce the symptoms and anxiety of patients and decrease frequency and duration of hospitalisation (1-6).

The aim of this study is to investigate the efficacy of pulmonary rehabilitation program in children with asthma.

PATIENTS AND METHOD

Twenty eight children with mild persistent or moderate asthma were included into a double blind, randomised study. Sixteen children (9 girls, 7 boys) with the mean age of 10.8 ± 2.3 were assigned to receive pulmonary rehabilitation program with their parents for 30 days (group I). Control group included 12 children (6 girls, 6 boys ) with the mean age of 10.2 ± 2.4 (group II). Children in both groups were comparable according to the stage of asthma and they had been using same drugs at least for six months.

Pulmonary rehabilitation program consisted of relaxation exercises, endurance exercises, breathing exercises and rhythmic mobilisation exercises. Patients and their parents had visited Physical Medicine and Rehabilitation Department at the first visit and they were thought to perform this program at home for 30 days. Symptom scores, medication scores (7), quality of life index (8) and pulmonary function tests were evaluated in rehabilitation and control group in the beginning of the study and after the one month period.

STATISTIC

The results in both group were given as mean scores and standard deviation. The findings indicated that non parametric methods were appropriate so Wilcoxon matched pairs test was used for difference between results at baseline and after the study. Mann-Whitney U test was used for comparing the groups. A p value of < 0.05 was regarded as statistically significant.

RESULTS

Symptom and medication scores and quality of life index of group I and group II were listed in table I. The groups did not differ on all parameters before the study (p > 0.05). Statistically significant decrease were found in symptom and medication scores in rehabilitation group (p < 0.05 ) and quality of life index was increased significantly in the same group (p < 0.05) (table I). Pulmonary function measures also significantly improved including vital capacity, forced vital capacity, forced expiratory volume in the first second of expiration, peak expiratory flow rate (PEF) and FEF25-75 in the rehabilitation group (p < 0.05). the best improvement were seen in FEF25-75 (10.09 % increase) and PEF (7.81% increase) values (table II).

 

Table I Symptom and medication score and quality of life index of group I (rehabilitation group) and control group


First visitSecond visitp

Rehabilitation group (Group I)
Symptom score0.63 ± 0.710.19 ± 0.40 0.01
(median: 0.5)(median: 0)
Medication score4.40 ± 1.703.50 ± 0.80 0.007
Quality of life Index6.02 ± 0.56.40 ± 0.40 0.009
Control Group
Symptom score0.67 ± 0.570.49 ± 1.40 0.16
(median: 0)
Medication score4.09 ± 0.794.06 ± 0.93 0.32
Quality of life Index6.15 ± 0.296.27 ± 0.49 0.16

 

Table II Pulmonary functions (% prediced values for age and height) of group I and control group

First visitSecond visit p

Group I
VC76.62 ± 8.6483.12 ± 12.38 0.05
FVC78.00 ± 8.8384.75 ± 10.76 0.02
FEV174.23 ± 11.6780.62 ± 12.27 0.009
PEF65.62 ± 8.5073.43 ± 7.32 0.001
FEF25-7575.73 ± 11.1285.31 ± 14.45 0.006
Group II
VC78.66 ± 10.3980.25 ± 6.25 0.75
FVC79.67 ± 8.6481.41 ± 7.07 0.36
FEV173.75 ± 7.1275.91 ± 5.43 0.15
PEF6.33 ± 7.2268.91 ± 9.16 0.21
FEF25-7574.54 ± 11.9676.66 ± 10.37 0.37

In control group no statistically significant differences were found in symptom and medication scores, in quality of life index, even in pulmonary function tests (p > 0.05).

DISCUSSION

Pulmonary rehabilitation program had both physiological and psychological beneficial effects on patients with chronic obstructive pulmonary diseases. Pulmonary rehabilitation relaxes the chest muscles, improves ventilation, decreases work of breathing and decreases the anxiety of patients and their parents.

In this study it was shown that pulmonary rehabilitation could improve the quality of life and pulmonary functions. Similar to our results Cambach et al had reported that quality of life and exercise capacity improved after the rehabilitation program (2). Field et al also had demonstrated that children with asthma had improved pulmonary function after the daily relaxation and massage therapy (4). They found best improvement in FEF25-75 values like our finding which reflects the small airway obstruction. These results mean PRP could lead improvement in airway obstruction and control of asthma.

In another study that were carried out by Cox et al it was shown that pulmonary rehabilitation had beneficial effects on endurance, psychological variables, quality of life, skills, coordination, smoking habits, airway obstruction and dyspnea (6). However bronchial hyperresponsiveness, need of pulmonary drugs and complaint of cough did not change. They followed patients for two years and long term effects of PRP were evaluated. Our study is a preliminary study and long term effects of PRP is well not known.

The cost effectiveness of PRP is another point that could discuss. In our group PRP was performed at home by parents and it makes less cost. If we had enough data about the results of PRP performed by physiotherapists we could make a comparison for these both methods. Effects on psychological variables and compliance could not be evaluated in this study.

In conclusion because of the beneficial effects on quality of life and pulmonary functions pulmonary rehabilitation should be placed as a component of management in childhood asthma. Further studies are needed to investigate the long term effects and cost effectiveness of PRP.


REFERENCES

1.Donna L. Frownfelter. Chest Physical Therapy and Pulmonary Rehabilitation, 2ª ed. Chicago: Year Book Medical Publishers; 1987.

2.Cambach W, Wagenaar RC, Koelman TW, et al. The long term effects of pulmonary rehabilitation in patients with asthma and chronic obstructive pulmonary diseases: a research synthesis. Arch Phys Med Rehabil 1999;80:103-11.

3.Barandun J. Value and cost of pulmonary rehabilitation. Schweiz Rundsch Med Prax 1997;86:1979-83.

4.Field T, Hanteleff BS, Reif MH, et al. Children with asthma have improved pulmonary functions after massage therapy. J Pediatr 1998;132:854-8.

5.Homnick DN, Marks JH. Exercises and sports in adolescents with chronic pulmonary diseases. Adolesc Med 1998;9:467-81.

6.Cox NJ, Hendricks JC, Binkhorts RA, et al. A pulmonary rehabilitation program for patients with asthma and chronic obstructive pulmonary diseases (COPD). Lung 1993;171:235-44.

7.Bousquet J, Guerrin B, Dotte A, et al. Comparison between rush immunotherapy with a standardised allergen and an alum adjuved pyridine extracted material in grass pollen allergy. Allergy 1985;15:82.

8.Juniper EF, Guyatt GH, Ferrie PJ, et al. Measuring quality of life in asthma. Am Rev Respir Dis 1993;147:832-8.

Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos